Media
Latest News
May 18, 2020
House Democrats passed a largely symbolic bill on May 15 rolling back two controversial tax provisions that had been slipped into the CARES Act, the $2 trillion stimulus law that Congress passed in March with overwhelmingly bipartisan support. The two tax provisions, which remove caps on individuals' and businesses' ability to write off net operating losses, are expected to deliver a $160 billion windfall to the wealthiest Americans, disproportionately benefiting hedge fund and real estate investors.
May 18, 2020
Gilead Sciences, the drug company behind the experimental Covid-19 therapy remdesivir, has upped the number of doses it’s donating to the federal government from 607,000 to around 940,000, STAT has learned.
May 15, 2020
President Trump’s top economic adviser said Friday that the White House is exploring a massive tax cut for corporations if they bring their supply chains from overseas to the U.S., a politically explosive suggestion that could reshape negotiations with Congress over the next stimulus package.
Issues:Coronavirus (COVID-19)
Image
May 15, 2020
There’s a tension at the heart of all of the plans to reopen the country in the midst of the coronavirus pandemic: The economy needs Americans to get back to work, but workplaces need employees and customers to feel that coming back won’t endanger their health or their lives.
Issues:Coronavirus (COVID-19)
May 14, 2020
WASHINGTON — As many as 2.4 million Texans didn’t get stimulus checks the federal government cut earlier this year because they are either immigrants or live with them, one way immigrants — even U.S. citizens — have been left out as Congress has poured trillions into coronavirus relief efforts.
Image
May 13, 2020
The chairman of a key congressional health subcommittee is demanding to see the formula used by the federal government to ration remdesivir, an experimental drug shown to speed the recovery of coronavirus patients.
Issues:Coronavirus (COVID-19)
May 13, 2020
Washington, D.C. – As the pandemic broadens and the Trump Administration bungles, U.S. Representative Lloyd Doggett (D-TX), Chairman of the Health Subcommittee on Ways and Means, and U.S. Representative Rosa DeLauro (D-CT), Chair of the Labor, Health and Human Services, and Education Appropriations Subcommittee, urge Secretary Azar to create a transparent process for distributing available doses of remdesivir and to swiftly release initial clinical trial findings. For physicians facing difficult prescribing decisions, this information is critical to ensure limited supplies go to the patients who will most benefit. This letter comes following the failure of Secretary Azar yet to respond to the lawmakers’ previous inquiry regarding taxpayer investments in remdesivir.
Image
May 10, 2020
As millions of Americans have lost jobs, stood in long lines for food and desperately needed federal relief to pay bills, thousands of other wealthy Americans stand to gain from a massive tax break.
Issues:Coronavirus (COVID-19)
May 8, 2020
U.S. companies continued their massive sell-off of medical masks overseas throughout March, well after the coronavirus began infecting Americans and draining hospitals of critical supplies and even as White House officials raised red flags, a USA TODAY investigation found.
Issues:Coronavirus (COVID-19)
May 8, 2020
Now that the Food and Drug Administration has authorized remdesivir for emergency use in seriously ill COVID-19 patients, the experimental drug is another step closer to full approval. That's when most drugs get price tags.